参考文献 [1] Storch CH, Hoeger PH.Propranolol for infantile haemangiomas - insights into the molecular mechanisms of action. Br J Dermatol,2010, May 8. [2] Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al, Propranolol for severe hemangiomas of infancy. N Engl J Med, 2008,358(24):2649-51. [3] Sans V, Dupuis E, Ezzedine K, et al.Propranolol for Severe Infantile Hemangiomas: Follow-Up Report. Pediatrics, 2009, 124: 423-431. [4] Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology, 2010,117(1):195-195.e4. [5] Naouri M, Schill T, Maruani A, et al.Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol,2010, 24(3): [6] Cheng JF, Gole GA, Sullivan TJ.Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol, 2010, Jun 11. [7] Li YC, McCahon E, Rowe NA, et al.Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol,. 2010, May 10. [8] Schwartz RA, Sidor MI, Musumeci ML, et al.Infantile haemangiomas: a challenge in paediatric dermatology. J Eur Acad Dermatol Venereol, 2010 ,24(6):631-638. [9] Zimmermann AP, Wiegand S, Werner JA,et al.Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol, 2010,74(4):338-342. [10] Holmes WJ, Mishra A, Gorst C,et al.Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg, 2010,125(1):420-421. [11] Denoyelle F, Garabédian EN.Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Otolaryngol Head Neck Surg, 2010 ,142(3):463-464. [12] Marsciani A, Pericoli R, Alaggio R, et al.Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer, 2010 ,54(1):176. [13] Truong MT, Chang KW, Berk DR, et al.Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr, 2010 ,156(2):335-338. [14] Buckmiller LM, Munson PD, Dyamenahalli U,et al.Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope,2010,120(4):676-681. [15] Lawley LP, Siegfried E, Todd JL.Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol, 2009 ,26(5):610-614. [16] Love JN, Sikka N. Are 1-2 tablets dangerous? (Beta-blocker exposure in toddlers). J Emerg Med, 2004,26:309–314. |